TNFRSF9 and prostate cancer: In addition, AA prostate cancer patients with high levels (>median) of both TNFRSF9 and PTN in their blood at diagnosis had the worst prostate cancer-specific survival independent of disease status [(Adjusted HR = 3.09 (1.36, 7.03)] (Fig. 7c).